Moreover, GPER protein expression is increased in breast tumors of patients treated only with tamoxifen and in tamoxifen resistant tumor tissues correlating with a poor relapse-free survival in patients treated with tamoxifen (Filardo et al., 2006; Ignatov et al., 2011). The gene discussed is GPER1; the disease is neoplasm.